Simple blood test could spot cancer earlier in High-Risk individuals
NCT ID NCT06726642
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a new blood test that looks for DNA fragments from tumors in people with hereditary cancer syndromes like Lynch syndrome or BRCA mutations. The goal is to see if the test can find cancers earlier than standard screening methods. Researchers will compare cancer detection rates between those getting the blood test and those receiving usual care, and also ask participants about their experience. If accurate, this test could offer a simpler, less invasive way to monitor high-risk patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cell-free DNA blood test
What this could lead to
If successful, this blood test could provide a less invasive way to detect cancer earlier in people with inherited cancer risks, potentially improving survival.
What could go wrong
This is an early-stage study testing the test's accuracy. It may not detect all cancers or could give false results. The test is not yet proven for routine use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROFIBROMATOSIS TYPE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BC Cancer Agency
NOT_YET_RECRUITINGVancouver, British Columbia, V5Z 4E6, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
-
Eastern Health
NOT_YET_RECRUITINGSt. John's, Newfoundland and Labrador, A1B 3V6, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
-
IWK Health Centre
NOT_YET_RECRUITINGHalifax, Nova Scotia, B3K 6R8, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Jewish General Hospital
NOT_YET_RECRUITINGMontreal, Quebec, H3T 1E2, Canada
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Sinai Health System
RECRUITINGToronto, Ontario, M5G 1X5, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Hospital for Sick Children
NOT_YET_RECRUITINGToronto, Ontario, M5G 1E8, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University Health Network
RECRUITINGToronto, Ontario, M5G 2M9, Canada
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Women's College Hospital
NOT_YET_RECRUITINGToronto, Ontario, M5S 1B2, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact